CSIMarket
 


Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 
 

Syros Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Syros Pharmaceuticals Inc asset turnover ratio, the ability of Syros Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 0.05 in the third quarter (Sep 30 2023), yet the ratio remained below the average, as SYRS's position remain challenging.

Within sector 211 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2023 compared to the preceding quarter from 1230 to 3521.


What is Asset Turnover Ratio?
What is Syros Pharmaceuticals Inc Market Share?


SYRS Asset Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Asset Change -49.82 % 46.94 % 38.31 % 36.73 % 39.26 %
Y / Y Revenue Change -3.32 % -54.86 % -45.97 % - -31.7 %
Asset Turnover Ratio (TTM) 0.05 0.04 0.06 - 0.13
SYRS's Total Ranking # 3521 # 1230 # 3003 # 2219 # 2840
Seq. Asset Change -19.41 % -13.18 % -16.03 % -14.6 % 135.99 %
Seq. Revenue Change 32.79 % -4.1 % - - -38 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 212
Healthcare Sector # 563
Overall Market # 3521

Asset Turnover Ratio Statistics
High Average Low
0.15 0.07 0.01
(Jun 30 2022)   (Dec 31 2019)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Xenetic Biosciences Inc   0.18 $ 2.355  Millions$ 13.287  Millions
Repare Therapeutics Inc   0.18 $ 56.692  Millions$ 322.094  Millions
Fate Therapeutics Inc   0.17 $ 106.213  Millions$ 616.111  Millions
Eiger Biopharmaceuticals Inc   0.17 $ 14.666  Millions$ 86.845  Millions
Blueprint Medicines Corporation  0.17 $ 201.145  Millions$ 1,195.504  Millions
Ligand Pharmaceuticals Incorporated  0.17 $ 130.258  Millions$ 775.269  Millions
Poseida Therapeutics Inc   0.17 $ 52.459  Millions$ 312.231  Millions
Durect Corp  0.17 $ 9.194  Millions$ 55.459  Millions
Nektar Therapeutics  0.16 $ 88.260  Millions$ 552.217  Millions
Liquidia Corporation  0.15 $ 18.317  Millions$ 122.840  Millions
Intelligent Bio Solutions Inc   0.15 $ 1.742  Millions$ 11.943  Millions
Arvinas Inc   0.15 $ 167.200  Millions$ 1,146.600  Millions
Cara Therapeutics inc   0.15 $ 21.225  Millions$ 146.310  Millions
Aadi Bioscience Inc   0.14 $ 23.255  Millions$ 161.445  Millions
Werewolf Therapeutics Inc   0.14 $ 25.725  Millions$ 179.234  Millions
Aligos Therapeutics Inc   0.14 $ 16.385  Millions$ 115.103  Millions
Uniqure N v   0.14 $ 111.899  Millions$ 787.572  Millions
Zevra Therapeutics Inc   0.14 $ 16.563  Millions$ 116.656  Millions
Impel Pharmaceuticals Inc   0.14 $ 8.223  Millions$ 58.290  Millions
Inspiremd Inc   0.14 $ 5.201  Millions$ 37.058  Millions
Marinus Pharmaceuticals Inc   0.14 $ 30.961  Millions$ 222.085  Millions
Royalty Pharma Plc  0.14 $ 2,324.234  Millions$ 16,716.148  Millions
Maxcyte inc   0.14 $ 38.047  Millions$ 276.532  Millions
Regenxbio Inc   0.14 $ 99.374  Millions$ 724.336  Millions
Arcutis Biotherapeutics Inc   0.14 $ 49.041  Millions$ 360.595  Millions
Ginkgo Bioworks Holdings Inc   0.14 $ 314.985  Millions$ 2,318.730  Millions
Mersana Therapeutics inc   0.14 $ 40.842  Millions$ 301.110  Millions
Somalogic Inc   0.14 $ 81.724  Millions$ 603.102  Millions
Opgen Inc   0.13 $ 3.070  Millions$ 23.224  Millions
Alector Inc   0.13 $ 96.312  Millions$ 729.281  Millions

Date modified: 2023-11-16T19:22:29+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com